Recordati SpA (REC) - Financial and Strategic SWOT Analysis Review

May 2021 | 60 pages | ID: RD190CD4A3DEN
GlobalData

Abstracts

Recordati SpA (REC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Recordati SpA (Recordati), a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculo-skeletal disorders and analgesia and urology diseases. It also offers cosmetics, dietary supplements, pregnancy test products, over the counter (OTC) and non-prescription pharmaceuticals, anti-infectives and others. It manufactures pharmaceutical chemicals, such as active pharmaceutical ingredients (APIs) and intermediates. The company sells its pharmaceuticals directly in the countries where it is present and through licensees in other places. Recordati is headquartered in Milan, Italy.

Recordati SpA Key Recent Developments

Apr 28,2021: Recordati to present the first quarter 2021 results and the 2021-2023 strategy and outlook update
Mar 18,2021: Recordati: Board approves the 2020 accounts
Feb 22,2021: Recordati: preliminary 2020 results confirm continued growth of operating income and net income. EBITDA +4.7% and adjusted net income +7.3%.
Oct 29,2020: Recordati: Profit growth in the first nine months of 2020. revenues -0.6%, ebitda +7.1%, adjusted net income +12.3%
Jul 30,2020: Recordati announces positive first half 2020 results. revenues +2.3%, EBITDA +11.4%, adjusted net income +16.8%

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Recordati SpA - Key Facts
Recordati SpA - Key Employees
Recordati SpA - Key Employee Biographies
Recordati SpA - Major Products and Services
Recordati SpA - History
Recordati SpA - Company Statement
Recordati SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Recordati SpA - Business Description
Business Segment: Orphan Drugs
Overview
Performance
Business Segment: Specialty and Primary Care
Overview
Performance
Geographical Segment: Africa
Performance
Geographical Segment: America
Performance
Geographical Segment: Australasia
Performance
Geographical Segment: Europe
Performance
R&D Overview
Recordati SpA - SWOT Analysis
SWOT Analysis - Overview
Recordati SpA - Strengths
Recordati SpA - Weaknesses
Recordati SpA - Opportunities
Recordati SpA - Threats
Recordati SpA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Recordati SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recordati SpA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recordati SpA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 28, 2021: Recordati to present the first quarter 2021 results and the 2021-2023 strategy and outlook update
Mar 18, 2021: Recordati: Board approves the 2020 accounts
Feb 22, 2021: Recordati: preliminary 2020 results confirm continued growth of operating income and net income. EBITDA +4.7% and adjusted net income +7.3%.
Oct 29, 2020: Recordati: Profit growth in the first nine months of 2020. revenues -0.6%, ebitda +7.1%, adjusted net income +12.3%
Jul 30, 2020: Recordati announces positive first half 2020 results. revenues +2.3%, EBITDA +11.4%, adjusted net income +16.8%
May 07, 2020: Recordati announces growth in the first quarter 2020. Revenues +12.1%, EBITDA +20.1%
Mar 18, 2020: Board approves the 2019 accounts sales € 1,481.8 million (+9.6%), EBITDA € 544.0 million (+9.0%). 2019 dividend € 1.00 (+8.7%)
Feb 14, 2020: Recordati announces preliminary 2019 results confirm continued growth of sales and profits. Sales +9.6%. EBITDA +9.0%

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Recordati SpA, Key Facts
Recordati SpA, Key Employees
Recordati SpA, Key Employee Biographies
Recordati SpA, Major Products and Services
Recordati SpA, History
Recordati SpA, Subsidiaries
Recordati SpA, Key Competitors
Recordati SpA, Ratios based on current share price
Recordati SpA, Annual Ratios
Recordati SpA, Annual Ratios (Cont...1)
Recordati SpA, Annual Ratios (Cont...2)
Recordati SpA, Interim Ratios
Recordati SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recordati SpA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recordati SpA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Recordati SpA, Performance Chart (2016 - 2020)
Recordati SpA, Ratio Charts
Recordati SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recordati SpA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021